The time window for pre-emptive transjugular intrahepatic portosystemic shunt could be extended to 5 days
- PMID: 38863871
- PMCID: PMC11165235
- DOI: 10.1016/j.heliyon.2024.e25824
The time window for pre-emptive transjugular intrahepatic portosystemic shunt could be extended to 5 days
Abstract
As recommended by Baveno VII consensus, the utilization of pre-emptive transjugular intrahepatic portosystemic shunt (pTIPS) has been considered as standard therapeutic approach for the management of acute variceal bleeding (AVB) associated with cirrhosis., but the 72-h window for pTIPS is too narrow. This study aimed to compare the clinical outcomes between patients who received <72 h pTIPS and 72 h-5d pTIPS. In this study, a total of 63 cirrhotic patients with AVB who underwent pTIPS between October 2016 and December 2021 were included in this retrospective study. They were divided into <72 h group (n = 32) and 72 h-5d group (n = 31), based on the timing of the intervention. The Kaplan-Meier curves demonstrated that there were no significant differences in the cumulative incidence of death (22.3% ± 7.4% vs. 19.9% ± 7.3%, log-rank P = 0.849), variceal rebleeding (9.7% ± 5.3% vs. 17.8% ± 7.3%, log-rank P = 0.406), OHE (28.5% ± 8.0% vs. 23.9% ± 8.0%, log-rank P = 0.641) and shunt dysfunction (8.6% ± 6.0% vs. 17.4% ± 8.1%, log-rank P = 0.328) between <72 h and 72 h-5d groups. In the total cohort, sarcopenia was identified as an independent risk factor for mortality (HR = 11.268, 95% CI = 1.435-88.462, P = 0.021) and OHE(HR = 12.504, 95% CI = 1.598-97.814, P = 0.016). In conclusion, the clinical outcomes of cirrhotic patients with AVB who underwent pTIPS within the 72-h to 5-day window were found to be comparable to those treated within the 72-h window.
Keywords: Acute variceal bleeding; Pre-emptive TIPS; Prognosis; Sarcopenia; Time window.
© 2024 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.J Hepatol. 2020 Nov;73(5):1082-1091. doi: 10.1016/j.jhep.2020.04.024. Epub 2020 Apr 24. J Hepatol. 2020. PMID: 32339602
-
Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding.Gut. 2023 Apr;72(4):749-758. doi: 10.1136/gutjnl-2022-326975. Epub 2022 Sep 9. Gut. 2023. PMID: 36328772
-
Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.Eur Radiol. 2018 Sep;28(9):3661-3668. doi: 10.1007/s00330-018-5360-z. Epub 2018 Mar 29. Eur Radiol. 2018. PMID: 29600476
-
Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions.World J Gastroenterol. 2021 Nov 28;27(44):7612-7624. doi: 10.3748/wjg.v27.i44.7612. World J Gastroenterol. 2021. PMID: 34908802 Free PMC article. Review.
-
Early transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a systematic review and meta-analysis.Eur Radiol. 2021 Jul;31(7):5390-5399. doi: 10.1007/s00330-020-07525-x. Epub 2021 Jan 6. Eur Radiol. 2021. PMID: 33409783
References
-
- Gines P., et al. Liver cirrhosis. Lancet. 2021;398(10308):1359–1376. - PubMed
-
- Baiges A., et al. Treatment of acute variceal bleeding in 2021-when to use transjugular intrahepatic portosystemic shunts? Clin. Liver Dis. 2021;25(2):345–356. - PubMed
-
- Rossle M. TIPS: 25 years later. J. Hepatol. 2013;59(5):1081–1093. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials